Drug Release Rate May be Customized Utilizing the Modular Approach of Dietary Forms of Dosage

Erin Opitz^*
*Correspondence: Erin Opitz, Department of Pharmacy and Medicines, Clínic de Barcelona, University of Barcelona, Barcelona, Spain, Email:

Description

The development of novel dosage forms and drug delivery systems has been a significant focus in pharmaceutical research to address the challenges of drug solubility, stability, and bioavailability. Customizing drug release rates has emerged as a pivotal strategy to achieve optimal therapeutic outcomes for a wide range of medical conditions. Dietary forms of dosage offer a modular approach that enables precise manipulation of drug release kinetics, providing greater control over drug availability and action in the body. This paper discusses the underlying principles of dietary forms of dosage and explores the potential benefits and applications of this innovative approach [1].

Dietary forms of dosage refer to pharmaceutical dosage forms that mimic the composition and properties of commonly consumed dietary products [2]. These forms are designed to integrate seamlessly with a patient's regular diet, thereby enhancing patient compliance and overall treatment effectiveness. By harnessing the unique characteristics of dietary components, such as fibres, lipids, and proteins, these dosage forms can modulate drug release profiles. The primary components of dietary forms of dosage include edible materials like starches, gums, cellulose derivatives, and lipids. These materials can be tailored to create a variety of delivery systems, such as tablets, capsules, beads, and films, allowing for versatile applications across different drugs and therapeutic indications.

The drug release from dietary forms of dosage can be achieved through various mechanisms, such as diffusion, erosion, or biodegradation. By altering the composition and structure of these dosage forms, drug release kinetics can be modified to suit the specific needs of individual patients and their medical conditions. The modular approach of dietary forms of dosage offers several advantages over conventional drug delivery systems. Each patient responds differently to medications, and their therapeutic requirements vary. The modular approach allows healthcare professionals to tailor drug release rates based on factors such as age, weight, severity of the condition, and patient preference. This customization can lead to improved treatment outcomes and reduced adverse effects.

Patient non-compliance is a significant challenge in healthcare, leading to treatment failure and disease progression. Dietary forms of dosage mimic familiar dietary products, making them more acceptable and easy to incorporate into patients' daily routines, thus promoting adherence to treatment regimens. Certain medications require frequent dosing due to their short half-lives or rapid clearance [3]. By customizing drug release rates, extended-release dietary forms of dosage can be developed, allowing for less frequent dosing while maintaining therapeutic efficacy. In some medical conditions, fluctuations in drug concentrations can lead to unpredictable therapeutic effects and adverse reactions. Modular drug release profiles enable a more controlled release of the drug, reducing variations in plasma concentrations and providing a more stable therapeutic response. For chronic diseases like diabetes, cardiovascular disorders, and neurodegenerative conditions, customized drug release rates can significantly improve patient outcomes and overall quality of life. Prolonged drug release in analgesic medications can provide prolonged pain relief while minimizing the risk of addiction and tolerance development. The unique needs of paediatric and geriatric patients can be addressed through customized drug release profiles that match their specific physiological characteristics and tolerances [4]. The modular approach of dietary forms of dosage aligns with the principles of personalized medicine, enabling treatments tailored to individual patients' needs and genetic profiles.

While the concept of dietary forms of dosage offers significant promise, certain challenges must be overcome. The stability of dietary components and their compatibility with the active pharmaceutical ingredient (API) need to be thoroughly investigated to ensure the longevity of the drug product. As this approach involves novel dosage forms and technologies, regulatory agencies may require robust safety and efficacy data before approving these products for commercial use. The production of dietary forms of dosage may require specialized manufacturing processes and equipment, which could add complexity to the drug development process.

Several techniques can be employed to achieve customized drug release rates using dietary forms of dosage. Coating the drug particles with polymers or lipids can modify the release kinetics. This can be achieved by adjusting the coating thickness or using polymers with different properties to alter the drug release profile. In matrix systems, the drug is dispersed within a matrix of hydrophilic or hydrophobic materials. The composition of the matrix can be altered to influence the drug release rate. Encapsulation involves entrapping the drug within microspheres or nanoparticles. By varying the size and composition of these carriers, drug release rates can be customized to match therapeutic requirements. Osmotic pumps are advanced devices that use osmotic pressure to control drug release. These pumps can be integrated into dietary forms of dosage to achieve precise and prolonged drug delivery [5].

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Thackaberry, Evan A. "Non-clinical toxicological considerations for pharmaceutical salt selection." Expert Opin Drug Metab Toxicol 8 (2012): 1419-1433.

Google Scholar, Crossref, Indexed at

2. Boksa, Kevin, Andrew Otte and Rodolfo Pinal. "Matrix-Assisted Cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion." J Pharm Sci 103 (2014): 2904-2910.

Google Scholar, Crossref, Indexed at

3. Dixit, R. P. and S. P. Puthli. "Oral strip technology: Overview and future potential." J Control Release 139 (2009): 94-107.

Google Scholar, Crossref, Indexed at

4. Ogihara, Takuo, Shigeki Matsumoto and Shuhei Ohnishi. "Functional characterization of active transport of progesterone to adrenal cells." J Pharm Pharmacol 56 (2004): 79-84.

Google Scholar, Crossref, Indexed at

5. Speer, Isabell, Maren Preis and Jörg Breitkreutz. "Dissolution testing of oral film preparations: Experimental comparison of compendial and non-compendial methods." Int J Pharm 561 (2019): 124-134.

Google Scholar, Crossref, Indexed at